RECHARGE Sub-Study to the Implantable Systems Performance Registry (ISPR)

Study Results

Results available

Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.

View full results

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

PHASE4

Total Enrollment

100 participants

Study Classification

INTERVENTIONAL

Study Start Date

2009-07-31

Study Completion Date

2013-07-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this study is to assess the recharge feature of the Activa RC System in patients who are receiving Deep Brain Stimulation (DBS) for Parkinson's Disease (PD), Essential Tremor (ET), or dystonia.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Chronic Effects of DBS in Parkinson's Disease and Dystonia

NCT01934296

Parkinson's Disease Isolated Dystonia

COMPLETED NA

The Motor Network in Parkinson's Disease and Dystonia: Mechanisms of Therapy

NCT03582891

Parkinson Disease Dystonia

ACTIVE_NOT_RECRUITING NA

Deep Brain Stimulation (DBS) for the Suppression of Tremor

NCT02087046

Tremor Action Tremor Essential Tremor +1 more

COMPLETED NA

Evaluation of Directional Stimulation During the Implantation of Deep Brain Stimulation (DBS) Leads

NCT01764815

Parkinson's Disease Essential Tremor

COMPLETED NA

Unlocking Dystonia From Parkinson's Disease With Directional DBS Technology

NCT03409120

Dystonia-Parkinsonism, Adult-Onset Parkinson Disease

COMPLETED NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Parkinson's Disease Essential Tremor Dystonia

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NA

Intervention Model

SINGLE_GROUP

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Patients receiving an Activa RC implant

Group Type EXPERIMENTAL

Activa RC

Intervention Type DEVICE

Patients receiving Activa RC as their first implantable neurostimulator or as a replacement implantable neurostimulator for deep brain stimulation

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Activa RC

Patients receiving Activa RC as their first implantable neurostimulator or as a replacement implantable neurostimulator for deep brain stimulation

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patient is enrolled in the Implantable Systems Performance Registry (ISPR) and will receive one Activa RC as their first implantable neurostimulator or as a replacement implantable neurostimulator for DBS.
* Patient must meet the indications in the Activa RC labeling.
* Patient (or patient's legally authorized representative) signs and dates the appropriate RECHARGE Informed Consent Form and/or Informed Assent Form and Authorization to Use and Disclose Health Information (HIPAA, US only).
* Patient has a diagnosis of Parkinson's Disease, Essential Tremor, or dystonia that meets the approved indication for Activa RC in the applicable geography.
* Patient with dystonia is 7 years of age or older (EU only).
* Patient with either PD or ET is 18 years of age or older.
* Patient (or caregiver) is able to use the patient programmer and correctly interpret the icons.
* Patient (or caregiver) is able and willing to regularly monitor the status of the rechargeable battery and respond appropriately.
* Patient (or caregiver) is able to locate the INS, position the recharge antenna for sufficient coupling, put on the recharge holster/belt, and monitor progress during the recharge session.
* Patient (or caregiver) is able to perform recharging activities for sufficient duration and frequency to maintain therapy and to perform recharging activities on an ongoing basis.
* Patient is willing and able to comply with protocol requirements.

Exclusion Criteria

* Patient has a contraindication identified in the Activa RC labeling.
* Patient who is currently enrolled in or plans to enroll in any concurrent drug and/or device study that may confound the results of the RECHARGE study.
* Patient has or will be implanted with a non-Medtronic Deep Brain Stimulation system component.

Minimum Eligible Age

7 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No